Journal of Molecular Medicine
Human epididymis protein 4 is a predictor of long-term mortality and major adverse cardiovascular events in patients with coronary artery disease
Study in peopleBiomarkers
Papers by Heinz Drexel
9 results
- European Journal of Preventive Cardiology
Lipid lowering therapy in venous thromboembolism. A Clinical Consensus Statement of the ESC Working Group on Aorta and Peripheral Vascular Diseases, the ESC Working Group on Cardiovascular Pharmacotherapy, the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, and the European Society of Vascular Medicine (ESVM)
ReviewInterventions - ADA Scientific Sessions 2025 Abstract
The LDL-C/Apo B Ratio Predicts Mortality in Heart Failure Patients both with and without Type 2 Diabetes
Study in peopleBiomarkers - ADA Scientific Sessions 2025 Abstract
Machine Learning Identifies Glypican 4 as Key Predictor of Five-Year Mortality in Heart Failure Patients with Prediabetes or Diabetes
Study in peopleBiomarkers
- ADA Scientific Sessions 2025 Abstract
Three Decades of Glucose-Lowering Therapy in Patients with Established Coronary Artery Disease—A Real-World Analysis
Study in peoplePopulations - ADA Scientific Sessions 2025 Abstract
Machine Learning Predicts T2DM Incidence Using Basic Clinical and Laboratory Parameters
Study in peopleBiomarkers - ADA Scientific Sessions 2025 Abstract
Cystatin C Predicts Mortality in Patients with Coronary Artery Disease Both among Subjects with and among Those without the Metabolic Syndrome
Study in peopleBiomarkers - ADA Scientific Sessions 2025 Abstract
The Visceral Adiposity Index Predicts the Development of Type 2 Diabetes Mellitus in Patients with Established Coronary Artery Disease
Study in peopleBiomarkers - ADA Scientific Sessions 2025 Abstract
Ceramides Surpass LDL-Cholesterol in Predicting Cardiovascular Mortality in Patients with as Well as in Patients without the Metabolic Syndrome
Study in peopleBiomarkers